Distinct Myeloid Progenitor–Differentiation Pathways Identified through Single-Cell RNA Sequencing By single-cell transcriptome profiling of pre–granulocyte-macrophage progenitors, investigators identified distinct myeloid differentiation pathways. [Nat Immunol] Abstract Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 & 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells Clinically used BCR-ABL1 inhibitors for the treatment of chronic myeloid leukemia do not eliminate leukemic stem cells. The authors describe the identification of novel dual MNK1 & 2 and BCR-ABL1 inhibitors, starting from the known kinase inhibitor 2. [J Med Chem] Abstract Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of MNGIE Investigators showed that ectopic expression of thymidine phosphorylase in the hematopoietic system restores normal nucleoside levels in plasma, as well as in tissues affected in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) such as small intestine, skeletal muscle, brain and liver. [Hum Gene Ther] Abstract Low C-Kit Expression Level Induced by Stem Cell Factor Does Not Compromise Transplantation of Hematopoietic Stem Cells Scientists determined whether diminished numbers of c-Kit receptors on hematopoietic stem cells (HSPCs) following their internalization induced by the binding of the cytokine stem cell factor would jeopardize transplantability of HSPCs. [Biol Blood Marrow Transplant] Abstract Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor Cells Researchers investigated the role of GLI1, the transcriptional activator of Hh signaling, in acute myeloid leukemia (AML) progenitor cells and explored the anti-AML effects of GLI small-molecule inhibitor GANT61. [Cell Physiol Biochem] Full Article CLINICAL RESEARCH Myasthenia Gravis Treated with Autologous Hematopoietic Stem Cell Transplantation Investigators report seven cases of severe myasthenia gravis treated with autologous hematopoietic stem cell transplant in which consistent, durable, symptom-free, and treatment-free remission was achieved. [JAMA Neurol] Full Article | Press Release Residual β-Cell Function Predicts Clinical Response after Autologous Hematopoietic Stem Cells Transplantation Scientists aimed to select the optimal quantitative index to assess pre-existing β-cell function and to explore its predictive function for clinical response after autologous hematopoietic stem cell transplantation therapy. [Stem Cells Transl Med] Abstract Predictive Value of High EVI1 Expression in AML Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in First CR Investigators determined whether the overexpression of EVI1 predicts poor outcome of AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR. [Bone Marrow Transplant] Abstract |